We provide you with 20 years of free, institutional-grade data for GNLX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GNLX. Explore the full financial landscape of GNLX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Yu Yong | Sale | -32,535 | $12.94 | $421,006 | 2023-12-18 |
| Thomas John | Sale | -9,000 | $13.23 | $119,035 | 2023-12-14 |
| Tyree James L | Sale | -9,000 | $12.91 | $116,231 | 2023-12-14 |
| Yu Yong | Sale | -36,800 | $11.85 | $435,995 | 2023-12-08 |
| Yu Yong | Sale | -18,665 | $10.26 | $191,555 | 2023-11-22 |
| Yu Yong | Sale | -18,135 | $13.04 | $236,455 | 2023-11-21 |
| Szalay Aladar | Sale | -5,704 | $19.4 | $110,638 | 2023-10-26 |
| Yu Yong | Sale | -5,200 | $19.11 | $99,351 | 2023-10-25 |
| Yu Yong | Derivatives Exercise | 5,200 | 2023-10-25 | ||
| Szalay Aladar | Sale | -49,987 | $19.97 | $998,365 | 2023-10-25 |
| Thomas John | Sale | -3,333 | $20.5 | $68,331 | 2023-10-16 |
| Yu Yong | Sale | -5,200 | $21.94 | $114,074 | 2023-10-11 |
| Yu Yong | Derivatives Exercise | 5,200 | 2023-10-11 | ||
| Szalay Aladar | Sale | -14,251 | $24.89 | $354,652 | 2023-10-10 |
| Szalay Aladar | Sale | -75,690 | $25.49 | $1,929,225 | 2023-10-04 |
| Szalay Aladar | Sale | -13,546 | $24.47 | $331,471 | 2023-09-29 |
| Szalay Aladar | Sale | -42,263 | $24.82 | $1,048,968 | 2023-09-27 |
| Yu Yong | Sale | -5,200 | $22.54 | $117,206 | 2023-09-27 |
| Yu Yong | Derivatives Exercise | 5,200 | 2023-09-27 | ||
| Szalay Aladar | Sale | -16,591 | $27.89 | $462,670 | 2023-09-25 |
| Yu Yong | Sale | -6,000 | $27.96 | $167,786 | 2023-09-21 |
| Yu Yong | Derivatives Exercise | 6,000 | 2023-09-21 | ||
| Ryder Sean | Sale | -10,000 | $30 | $300,000 | 2023-09-21 |
| Ryder Sean | Derivatives Exercise | 10,000 | 2023-09-21 | ||
| Szalay Aladar | Sale | -30,292 | $23.2 | $702,805 | 2023-09-20 |
| Szalay Aladar | Sale | -32,167 | $26.21 | $843,123 | 2023-09-20 |
| Thomas John | Sale | -6,667 | $21.67 | $144,454 | 2023-09-18 |
| Yu Yong | Sale | -10,400 | $21.56 | $224,201 | 2023-09-18 |
| Yu Yong | Derivatives Exercise | 10,400 | 2023-09-18 | ||
| Szalay Aladar | Sale | -44,308 | $21.26 | $941,957 | 2023-09-15 |
| Yu Yong | Sale | -29,800 | $21.14 | $629,927 | 2023-09-15 |
| Smither John W | Sale | -900 | $20.78 | $18,702 | 2023-09-14 |
| Tyree James L | Grant, award...etc | 3,460 | 2023-09-13 | ||
| Mirabelli Mary | Grant, award...etc | 3,460 | 2023-09-13 | ||
| Thomas John | Grant, award...etc | 3,460 | 2023-09-13 | ||
| Smither John W | Grant, award...etc | 6,920 | 2023-09-13 | ||
| Smither John W | Initial | 2023-09-13 | |||
| Szalay Aladar | Sale | -52,616 | $21.39 | $1,125,204 | 2023-09-13 |
| Smalling Ralph | Grant, award...etc | 10,000 | 2023-09-12 | ||
| Jewett Caroline | Grant, award...etc | 20,000 | 2023-09-12 | ||
| Szalay Aladar | Sale | -37,277 | $24.12 | $899,166 | 2023-09-11 |
| Yu Yong | Sale | -19,800 | $24.7 | $489,060 | 2023-08-30 |
| Jewett Caroline | Sale | -515 | $23.73 | $12,221 | 2023-08-22 |
| Smalling Ralph | Sale | -935 | $23.73 | $22,188 | 2023-08-22 |
| Samuelson Doug | Sale | -1,297 | $23.73 | $30,778 | 2023-08-22 |
| Yu Yong | Sale | -3,265 | $23.73 | $77,478 | 2023-08-22 |
| Ryder Sean | Sale | -328 | $23.73 | $7,783 | 2023-08-22 |
| Cappello Joseph | Sale | -3,265 | $23.73 | $77,478 | 2023-08-22 |
| Zindrick Thomas | Sale | -8,349 | $23.73 | $198,122 | 2023-08-22 |
| Smalling Ralph | Initial | 2023-07-03 | |||
| Jewett Caroline | Initial | 2023-07-03 | |||
| Tyree James L | Grant, award...etc | 9,000 | 2023-05-02 | ||
| Mirabelli Mary | Grant, award...etc | 1,000 | 2023-05-02 | ||
| Woodward Gabe | Grant, award...etc | 1,000 | 2023-05-02 | ||
| Thomas John | Grant, award...etc | 9,000 | 2023-05-02 | ||
| Zhang Qian | Grant, award...etc | 6,000 | 2023-05-02 | ||
| Zindrick Thomas | Grant, award...etc | 23,000 | 2023-05-02 | ||
| Ryder Sean | Grant, award...etc | 900 | 2023-05-02 | ||
| Samuelson Doug | Grant, award...etc | 3,600 | 2023-05-02 | ||
| Yu Tony | Grant, award...etc | 9,000 | 2023-05-02 | ||
| Cappello Joseph | Grant, award...etc | 9,000 | 2023-05-02 | ||
| Zhang Qian | Open Market Purchase | 200 | $6.25 | 2023-01-31 | |
| Szalay Aladar | Initial | 2023-01-25 | |||
| Zhang Qian | Initial | 2023-01-25 | |||
| Yu Tony | Initial | 2023-01-25 |
The information provided in this report about GNLX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Genelux Corp.(NASDAQ:GNLX) 
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac...
Website: https://www.genelux.com
Founded: 2001
IPO Price: $6 (Jan 26, 2023)
Full Time Employees: 15
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends